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ABSTRACT
Currently, there is limited research reporting the symptoms of long COVID among athletes,
and the recommendations for athletes returning to competition/training who have experi-
enced long COVID symptoms. Therefore, the aim of this systematic review is to synthesise
the recommendations for returning athletes who have experienced long COVID symptoms.
The protocol was registered in PROSPERO under CRD42021265939. Two authors searched the
electronic databases PubMed, Embase, Scopus, the Cochrane Library, Web of Science,
CINAHL, PsycINFO, and SPORTDiscus from August 2019-July 2021. Search terms included
words related to “long COVID”, “athlete” and “return”. Data extraction was completed for
each study by two independent investigators for: (1) first author name; (2) year of publica-
tion; (3) journal; (4) Definition of athlete (i.e. elite or non-elite) (5) Recommendations
reported. A total of 220 records were found. Following title and abstract screening, 61 studies
were eligible for full text screening. Overall, no studies, commentaries, editorials or reviews
provided specific recommendations for “long COVID” defined as COVID-19 signs and symp-
toms lasting for over 4weeks as a result of COVID-19 infection. In addition, we found no
studies which reported symptoms of athletes suffering from long COVID. Despite the lack of
evidence, we did find eight separate professional recommendations for managing “long-term
effects” and “ongoing” or “prolonged” symptoms and COVID-19 complications among ath-
letes. Practitioners should be aware of both mental and physical symptoms of long COVID,
and additional considerations may be required for athletes who have undergone intensive
care. The present review provides a list of recommendations based on existing literature that
may be followed and implemented for returning athletes.
KEY MESSAGES
 Further research, including longitudinal research of athletes who have tested positive for
COVID-19, is required to develop evidenced-based guidelines for athletes with ongoing
COVID-19 symptoms.
 Prior to returning to play after COVID-19 infection, a thorough medical history, physical and
psychological examination should be conducted by a medical professional.
 Athletes should continue to monitor and record their own physical and psychological
markers of health.
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The unprecedented rate at which COVID-19 has
spread worldwide, as well as its scale of reach and the
prolonged duration of the pandemic, was unexpected.
This new, highly contagious disease moved rapidly
across China and spread to more than 200 countries,
infecting 233,503,524 people by October 2021 [1].
COVID-19 signs and symptoms can be classified in
three stages. The first stage of COVID-19 infection is
defined as ‘Acute COVID-190 and refers to the initial
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signs and symptoms of COVID-19 which last for up to
4weeks. ‘Ongoing symptomatic COVID-190 is defined
as signs and symptoms lasting 4–12weeks, whilst
“post-COVID-19 syndrome” is defined as signs and
symptoms of COVID-19 infection that last longer than
12weeks attributable to COVID-19 infection. “Long
COVID” is used to describe “signs and symptoms that
continue or develop after acute COVID-19, it includes
both ongoing symptomatic COVID-19 and post-COVID-
19 syndrome” [2]. The most commonly reported symp-
toms of long COVID are: fatigue, breathlessness,
muscle soreness, chest pain, difficulty concentrating,
anxiety, and depression [3]. To date, the vast majority
of studies have focussed on acute COVID-19 with few
focussing on long COVID [4].
However, recent studies have suggested that the
prevalence of long COVID is high. For instance, accord-
ing to WHO data, around 25% of people who have
had COVID-19 experience at least four weeks of symp-
toms, and 10% of people who have had COVID-19
experience symptoms for more than 12weeks [5].
Moreover, a UK-based study estimated 945,000 people
living in private households were experiencing long
COVID symptoms in July 2021 [6]. The symptoms of
long COVID can be debilitating, with 19.3% of those
with self-reported long COVID reporting that their abil-
ity to carry out normal activities of daily living had
been limited “a lot” [6].
A review of long COVID research found evidence
that the term “long COVID” includes three previously
identified syndromes including: post-intensive care
unit syndrome (PICS), long-term organ damage, and
post-viral syndrome [7]. In addition, long COVID may
also be an active disease, characterised by an inflam-
matory response, continued viral activity and a risk of
blood clotting disorders [7].
Exercise has been recommended to reduce the risk
of severe infection in the general population, and for
patients recovering from COVID-19, to reduce the
impact of physical de-conditioning associated with the
disease. Moreover, exercise may be particularly benefi-
cial to aid in the recovery of the musculoskeletal sys-
tem following COVID-19 infection. Indeed, a recent
review concluded that from the onset of COVID-19
symptoms and through the most severe stages of the
disease, musculoskeletal symptoms, including myalgia,
arthralgia, and fatigue, were frequently experienced
[8]. Considering this, specific considerations are
required for athletes who are more likely to engage in
strenuous exercise regimes than the general popula-
tion, which may increase risk of further COVID-19 com-
plications [9].
An important goal for sporting organisations and
associated staff (e.g. managers, coaches, sport physi-
cians etc.) is to supervise athletes in returning to train-
ing and competition following an illness or injury. This
is of upmost importance for the professional athlete as
uninterrupted training often at a high intensity is essen-
tial for both athletic and career progression. Therefore,
in the context of long COVID decisions relating to
“return to play” need to balance the potential adverse
impact of training on health while experiencing symp-
toms of long COVID with the diminishing levels of fit-
ness, from a pause in training or training at a low
intensity, that will impact sporting performance [10].
However, currently there is limited research which
reports the symptoms of long COVID among athletes,
and the recommendations for athletes returning to com-
petition/training who have experienced long COVID
symptoms. Therefore, the aim of this review is to synthe-
sise the recommendations for returning athletes who
have experienced long COVID symptoms.
Method
The protocol was registered in PROSPERO under
CRD42021265939. Two authors searched the electronic
databases PubMed, Embase, the Cochrane Library,
Web of Science, CINAHL, PsycINFO, and SPORTDiscus
from August 2019-July 2021. Search terms included
words related to “long COVID”, “athlete” and “return-
to-play” (Appendix 1). In addition, we hand searched
the reference lists of eligible articles.
All study designs were eligible providing they met
the following inclusion criteria:
1. Studies that reported recommendations for ath-
letes (elite and non-elite) who have suffered from
long COVID-19 symptoms (defined as over 4
weeks or more of COVID-19 symptoms).
2. Studies that reported symptoms of athletes suffer-
ing from long COVID.
3. Studies in English, Spanish, French, or Italian.
4. Reviews, expert consensus, professional view-
points and editorials which included specific
recommendations.
5. Peer reviewed articles.
Studies outside the language criteria were
excluded.
Title, abstract, and full-text screening was per-
formed in pairs and any disagreement between
reviewers was resolved by a third senior reviewer.
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Data extraction
Data extraction was completed for each study by two
independent researchers for: (1) first author name; (2)
year of publication; (3) journal; (4) definition of athlete
(i.e. elite or non-elite) (5) recommendations which
applied to athletes with ongoing Covid-19 symptoms.
As we did not find any studies which reported data
from athlete populations with long COVID, we did not
extract data on the symptoms, length of COVID symp-
toms, type of sport, study design and population
demographics as planned in our protocol.
Following data extraction we synthesised the litera-
ture to provide an overview of the recommendations
for each syndrome which can be classified as “long
COVID” [7], including:
1. Post-intensive care unit syndrome (PICS): cogni-
tive, psychiatric, and/or physical disability after
treatment in an intensive care unit [11].
2. Long-term organ damage: damage to the organs
which persists after Covid-19 infection.
3. Post-viral syndrome: persistent symptoms at the
post-viral stage [12].
4. Long COVID as a distinct syndrome and active dis-
ease characterised by an inflammatory response,
continued viral activity and a risk of blood clotting
disorders [7].
Results
A total of 220 records were found. Following title and
abstract screening 60 studies were eligible for full text
screening (Figure 1). Overall, no studies, commenta-
ries, editorials or reviews provided specific recommen-
dations for “long COVID” defined as COVID-19 signs
and symptoms lasting for over four weeks as a result
of COVID-19 infection. In addition, we found no stud-
ies which reported symptoms of athletes suffering
Records identified from: 
Embase (n= 49) 
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Figure 1. PRISMA flow diagram. From ref. Page et al. [30]. For more information, visit: http://www.prisma-statement.org/
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from long COVID. However, we did find eight separate
professional recommendations for managing “long-
term effects” and “ongoing” or “prolonged” symptoms
and COVID-19 complications among athletes (Table 1).
Due to the lack of experimental or observational stud-
ies, we did not use the Newcastle Ottawa Scale to
assess the study quality as planned in the protocol.
Figure 2 is based on the recommendations across
the literature, for athletes returning to exercise follow-
ing ongoing COVID-19 symptoms.
Discussion
Given that long COVID has been used as an umbrella
term to refer to four syndromes: PICS, long-term organ
damage, post-viral syndrome and an active disease,
we will discuss the recommendations made for each
syndrome in turn, and then provide an overall sum-
mary of the recommendations for the management of
long COVID.
Post-intensive care unit syndrome (PICS)
Research has shown that athletes are at lower risk of
severe COVID-19 symptoms than the general popula-
tion. However, for people who have been admitted to
an intensive care unit, including athletes, there may
be a risk of PICS. PICS refers to a combination of emo-
tional and physical symptoms following intensive care
[21]. No studies reported the symptoms of PICS
among athletes, or provided recommendations for
athletes experiencing PICS. However, the BASES con-
sensus on return to play recommends that anyone
who required hospitalisation due to COVID-19 infec-
tion should be managed by a multi-disciplinary team
including medical specialists [17].
Long-term organ damage
Research has found COVID-19 may manifest in various
organs including the heart, lungs, kidney, intestine
and the brain [22]. Several studies referred to the risk
of long-term organ damage among athletes, in par-
ticular the risk of myocarditis and pneumonia, which
are associated with COVID-19 infection. The literature
suggested an array of tests to assess the physical
health of athletes that will likely identify any long-
term organ damage. It should also be noted here that
among these tests are also assessments to monitor
mental health and thus will be discussed here also.
Table 2 presents the rationale for different tests rec-
ommended in the literature, which may be selectively
done according to the athletes signs and symptoms.
All athletes are recommended to undertake a med-
ical history and physical examination. For athletes with
persistent symptoms, it is recommended that a 12-
lead ECG and MRI are conducted to identify myocardi-
tis and/or myocardial oedema. If myocarditis or myo-
cardial oedema is detected, then rehabilitation
guidelines should be followed specific to these com-
plications. Following a cardiac assessment, several
studies suggest performing cardiopulmonary exercise
testing (CPET).
Respiratory tests are also recommended following
ongoing symptoms, including chest X-ray, conducting
spirometry and Exhaled Nitric Oxide testing (FeNO
testing). Following any abnormalities in readings or
persistent unexplained symptoms, the following meas-
ures may provide a more comprehensive assessment:
CT Thorax, ventilation–perfusion scanning, body ple-
thysmography and testing inspiratory muscle strength.
Blood tests are also a useful tool to assess for bio-
markers of ongoing damage to the organs. Blood tests
referenced in the literature included: D-dimer,
Troponin, Brain Natriuretic Peptide, C-reactive protein,
blood cell count and Creatinine, to identify possible
organ damage. We also suggest that assessing muscle
enzymes (Creatine Kinase and adolase) may be useful,
as previous studies have reported an association
between Covid-19 and rhabomyolysis. Even though
rhabomyolysis is resolved after Covid-19, exercise can
aggravate muscle injury [23].
In addition to cardiac, pulmonary and blood tests,
Halle and colleagues also recommend clinical neuro-
logical and musculoskeletal testing [14]. We suggest
that for athletes who have undergone a baseline
assessment of concussion symptoms using the sports
concussion assessment tool (SCAT) [24] prior to
COVID-19 contraction, it may be of value to compare
symptom evaluation, cognitive screening, neurological
screening and delayed recall values recorded in a
SCAT test to post-COVID-19 values to identify signifi-
cant differences pre and post scores which may war-
rant further evaluation. In terms of musculoskeletal
testing, testing should be carried out to identify any
areas of pain or weakness, which may impede an ath-
lete’s return to play. A study found that muscle pain
was common among those hospitalised with COVID-
19 [25]. In addition, a period of de-training due to
COVID-19 illness may have also resulted in muscle
weakness or tightness which could contribute to
future injury risk. Muscle pain, weakness or tightness
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may need to be addressed by a physiotherapist or a
strength and conditioning coach.
Mental health screening was not included in
the primary evaluation of athletes returning to play.
However, given that population studies have found
symptoms of anxiety and depression among people
suffering from long COVID, we have included mental
health screening in the initial evaluation. Examples of
Athlete with ongoing symptoms
Ongoing physical and psychological monitoring (heart rate, 
heart rate variaon, oxygen saturaon, sleep, acvity, 
fague and mood).
Repeat cardiac, respiratory, blood test at one year or 
earlier if symptoms return.
 
Assessment of medical history and physical/psychological 
examinaon 
• Cardiac tesng 
• Respiratory tesng
• Blood tests 
• Neurological tesng
• Mental health screening
No abnormalies detected
• Cardiopulmonary Exercise Tesng (CPET) 
including measurement of O2-saturaon 
during exercise or blood gas analysis 
aer exercise and exercise ECG
• 24-hour Holter ECG
Abnormalies detected 
Rehabilitaon guidelines should be followed 
for the specific condion detected. For 
example, if Myocardis is detected then 
exercise should be restricted for 3-6 months 
as per guidelines.
Graded return to play considered when athlete is: 
Symptom free for 7 days and is able to carry out acvies 
of daily living and walk 500m without excessive fague, 
or breathlessness.
Ongoing physical and psychological 
monitoring (heart rate, heart rate variaon, 
oxygen saturaon, sleep, acvity, fague 
and mood).
Repeat cardiac, respiratory, blood test at 3 
and 6 months, then annually for the first 
two years. 
Graded return to play considered when 
a complete recovery is made and 




Figure 2. Flow diagram of athlete protocol for managing ongoing COVID-19 signs and symptoms.
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mental health screening tools which may be of value
are the Injury- Psychological Readiness to Return to
Sport Scale (I-PRRS) recommended by BASES as a
monitoring tool during a graded return to play [20],
and screening for depression and anxiety. However,
ultimately mental health evaluation should be tailored
to the needs of the athletes. For example, athletes
may feel more comfortable discussing their mental
health with a sports psychologist than using a screen-
ing tool presented by a doctor. Athletes with previous
history of mental health problems should also be
offered tailored support e.g. an athlete with an eating
disorder may need to seek specialist support.
Post viral syndrome
A review of long-term Covid symptoms found the
most commonly reported long-term outcome of
COVID-19 was fatigue [26]. The BASES consensus on
return to play following COVID-19 infection recom-
mends that athletes should be able to complete activ-
ities of daily living and walk 500m without excessive
breathlessness or fatigue. If the athlete can carry out
the activities of daily living without excessive fatigue
and has been symptom free for 7 days with no further
structural damage from COVID-19, athletes are recom-
mended to follow a medically supervised graded
return to play. It should be noted that the athlete
should not be undergoing any treatment or medica-
tion which could mask COVID-19 symptoms prior to
being cleared to return to play. BASES also suggests
2–3 days graded return to play for everyday lost to ill-
ness. When return to play is resumed, then training
should be increased firstly by frequency, then duration
and finally intensity [20]. The Stanford Hall consensus
statement for post-COVID rehabilitation recommends
Table 2. Tests to assess physical (and mental) health of athletes.
Measures taken Reason for taking the measure
Cardiovascular tests
1) 12-lead ECG, echocardiography, cardiac MRIa Screen for cardiovascular complications, identify Myocarditis/
myocardial oedema
Cardiopulmonary tests
1) CPET with ECG including measurement of respiratory efficiency, O2-
saturation during exercise or blood gas analysis after exercise
(Recommended by Halle et al. for people with more severe symptoms
and/or post-pneumonia or myocarditis).
Identify subclinical impairment in cardiopulmonary system, e.g.
arrhythmias, premature dyspnoea, impaired diffusion capacity and
guide future training intensities if returning to play.
Respiratory tests
1) Chest X-ray Identify Pneumonia
Spirometry: Bronchodilator challenge and
bronchoprovocation testing
Identify airway disease (may have been undiagnosed or exacerbated due
to COVID-19)
Spirometry: Vital capacity and forced expiratory volume Identify impaired lung function
FeNO testing Identify post inflammatory bronchoconstriction
2) CT Thorax (if significant suspicion of thromboembolic or
intrapulmonary abnormalities)
Covid-19 related lung damage and pulmonary vasculature pathology
3) Ventilation–perfusion scan (if O2 desaturation during CPET testing is
identified and CT thorax scan is normal)
Identify microemboli.
4) Body plethysmography (Recommended by Halle et al. for people
with identified pulmonary problems or ongoing symptoms of
pulmonary disfunction e.g. breathlessness).
Measure residual volume and total lung capacity
5) Inspiratory muscle strength assessed To identify potential causes behind unexplained exercise
limitation/dyspnoea
Blood tests
1) D-dimer Identify pulmonary embolism
Troponin (hs-cTn or cTn levels test)b Detect damage to the heart
Brain Natriuretic Peptide Detect heart failure
C reactive protein Assess inflammation
Blood cell count Assess inflammation
Creatinine Assess kidney function
Neurological test
1) Clinical neurological exam Test for signs of damage to the neurological system, and to test for risks
to safety during exercise e.g. symptoms of Vertigo.
Musculoskeletal test
1) Musculoskeletal assessment, e.g. Strength, flexibility,
muscular endurance.
Musculoskeletal assessment may be advisable to identify areas of
weakness following a period of deconditioning.
Mental health
1) Injury-Psychological Readiness to Return to Sport To help identify if referral to mental health specialist/sports psychologist
may be beneficial.
Mental health screening i.e. screen for symptoms of
depression, anxiety.
To help identify if referral to mental health specialist/sports psychologist
may be beneficial.
CPET: Cardiopulmonary exercise testing; ECG: Electrocardiogram.
aAthletes may have anomalies in cardiac screening as a result of sport/exercise training, e.g. wall motion anomalies and pericardial effusion [13].
bRaised troponin levels may also be an outcome of high intensity sport/exercise13.
ANNALS OF MEDICINE 1941
that the first week of returning to exercise should con-
sist of low level stretching and light muscle strength-
ening activity [27]. In addition, ongoing monitoring
including physical and psychological measures, for
example, heart rate, heart rate variation, oxygen satur-
ation, sleep, activity, fatigue and mood should be con-
tinued to ensure that return to play is graded, and
that rest and recovery is sufficient. In female athletes,
monitoring the menstrual cycle may also be beneficial
to identify if psychological and biological fluctuations
may be explained by changes in fluctuating hormones.
Menstrual cycle monitoring can also be an indication
of overall health e.g. stress management and energy
balance [28].
Interestingly, the National Institute for Health
Research draws parallels between the symptoms and
causes of long COVID symptoms and overtraining syn-
drome (OTS) [7]. OTS is a more extensively researched
syndrome in the field of sports science than long
COVID, and in light of a lack of specific guidance
regarding return to play following long COVID, draw-
ing upon guidance recommended for OTS may assist
practitioners and athletes with the management of
long COVID fatigue. For example, it is recommended
to manage OTS, that athletes and practitioners main-
tain regular competition and training records of per-
formance, avoid excessively monotonous training, are
aware of external stresses and how to minimise their
impact, and that regular athlete-practitioner communi-
cation is maintained [29]. It is also important that
practitioners do not misdiagnose long COVID as OTS.
Long COVID as a distinct disease
Finally, long COVID has also been identified in recent
studies as potentially an active disease, with an inflam-
matory response and viral activity, and occasionally
blood clotting disorders. As previously discussed, the
literature recommends that return to play does not
resume until the athlete has rested for 10 days, is
7 days symptom-free without treatment or medication
for symptoms and does not have any structural organ
damage. Therefore, if an athlete is experiencing active
COVID-19 disease then they should not return to play.
It is important to highlight the possibility of ongoing
active COVID-19 disease, as athletes with ongoing viral
and inflammatory activity may be at heightened risk
of structural organ damage. Thus, reinforcing the need
for repeated testing for organ damage among athletes
who are experiencing ongoing symptoms.
Limitations and recommendations
Our review was largely limited due to the ambiguity
of the term “long COVID” in the literature. Long
COVID is a relatively recent identified condition, and
future studies which examine long COVID should con-
sider that different pathologies may result in similar
symptoms. In addition, whilst there is recognition that
athletes who are recovering from or have COVID-19
may be at risk of mental health problems, there were
limited recommendations for how symptoms of poor
mental health may present in the long-term and also
how to minimise these symptoms. To add to this, rec-
ommendations were not stratified by sport, or by ath-
lete level of play i.e. elite vs recreational athlete,
instead recommendations were often stratified by
“mild/moderate symptoms” and “severe symptoms”.
However, long-term COVID-19 symptoms can occur in
those who experience mild/moderate and severe
symptoms of COVID-19. Research which explicitly stud-
ies the long-term effects of COVID-19 among athletes
and provides evidence-based recommendations for
athletes with long-term symptoms is needed.
Particularly as many of the recommendations for ath-
letes require intensive medical investigation. Given the
lack of evidence for the effects of long COVID for ath-
letes, it may be assumed that many of these test are
precautionary measures, which could be costly and
potentially unethical to conduct if evidence emerges
of a limited long term clinical impact of Covid-19
among athletes. Sport-specific, and level of athlete
recommendations may also be warranted. For
example, it is plausible a recreational athlete may
have limited resources to continue home monitoring
(e.g. heart rate monitoring using ECGs) and to carry
out the range of tests required to confirm return to
play is safe, therefore, feasible guidelines may be
needed for recreational athletes. Different levels of
physical fitness between elite and recreational athletes
may also be important when developing specific rec-
ommendations due to different physical fitness and
physical capacity levels.
Conclusion
Current literature on long COVID has highlighted a
range of syndromes which may be defined as long
COVID. Practitioners should be aware of both mental
and physical symptoms of long COVID, and additional
considerations may be required for athletes who have
undergone intensive care. Overall, based on the cur-
rent literature, it is suggested that an athlete seeks
medical clearance prior to returning to training or
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competition. A multidisciplinary medical clearance
should include a comprehensive screening of the
cardiovascular, pulmonary, neurological and muscular
systems. Appropriate and tailored services, including
tele-health support, should be available to athletes
during the infection in order to closely follow-up the
disease course. If there is no structural damage and
no further symptoms of COVID-19 for at least 7 days,
then a graded return to play may be resumed.
Continuous daily monitoring can be undertaken by
the athlete, being recorded and reported to practi-
tioners and coaches. Clinical re-evaluation should be
undertaken a maximum of one year later, although it
may be beneficial to carry out re-evaluation earlier if
the athlete is considered at risk. If symptoms return, it
may be an indication that the athlete is experiencing
continued inflammation and viral load as a result of
long COVID. In this case, we recommend a suspension
of training/competition followed by immediate re-
evaluation of symptoms and organ damage status.
Importantly, the current recommendations for the
management of long COVID among athletes should
continue to be adapted in light of new high-quality
evidence, including longitudinal research.
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Appendix 1
((LONG OR LONG-TERM OR post-acute OR long-tail OR per-
sistent OR ‘long term’) AND (CORONAVIRUS OR COVID-19
OR COVID OR SARS-CoV-2)) OR (‘post COVID syndrome’ OR
‘post-covid syndrome’ OR ‘long haul covid’ OR ‘covid long
haulers’))) AND (ATHLE OR SPORT OR ‘athlet rehab’ OR
‘pro athlete’ OR ‘sport rehab’ OR ‘return to play’ OR
‘return to train’ OR ‘athle recovery’ OR ‘sport recovery’
‘return to competition’ OR ‘competition return’).
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